Impact of peripheral vascular disease on short-and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era
Percutaneous Coronary Intervention
Peripheral Vascular Diseases
In contemporary PCI utilizing DESs, glycoprotein IIb/IIIa inhibitors, and clopidogrel, PVD is associated with a higher in-hospital and 4-year all-cause mortality. In our study, this difference in long-term survival was mainly driven by a higher rate of comorbidities in the PVD population that underwent PCI.